Aspire Private Capital’s Labcorp LH Stock Holding History

Aspire Private Capital’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-13	Closed	-$2.9K	–	434
2024 Q3	$2.9K	Hold	13	–	–	﹤0.01%	521
2024 Q2	$2.65K	Hold	13	–	–	﹤0.01%	537
2024 Q1	$2.84K	Hold	13	–	–	﹤0.01%	551
2023 Q4	$2.95K	Hold	13	–	–	﹤0.01%	528
2023 Q3	$2.61K	Sell	13 -2	-13%	-$422	﹤0.01%	543
2023 Q2	$3.14K	Hold	15	–	–	﹤0.01%	500
2023 Q1	$2.98K	Sell	15 -1	-6%	-$206	﹤0.01%	497
2022 Q4	$3.3K	Hold	16	–	–	﹤0.01%	478
2022 Q3	$3K	Hold	16	–	–	﹤0.01%	483
2022 Q2	$3K	Hold	16	–	–	﹤0.01%	457
2022 Q1	$4K	Hold	16	–	–	﹤0.01%	425
2021 Q4	$4K	Sell	16 -1	-6%	-$248	﹤0.01%	454
2021 Q3	$4K	Hold	17	–	–	﹤0.01%	410
2021 Q2	$4K	Buy	+17	New	+$3.87K	﹤0.01%	421

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Aspire Private Capital's LH Position: Q4 2024 in Review

Aspire Private Capital sold out of Labcorp (LH) in Q4 2024, closing a stake of 13 shares — an estimated $2.9K sold.

Aspire Private Capital first reported a position in LH in Q2 2021 and held it in 14 quarters. The position peaked at $4K in Q1 2022. 927 funds tracked by Wall St. Rank hold LH as of Q4 2024.

Aspire Private Capital reported no remaining Labcorp position as of Q4 2024 after selling out during the quarter.
Aspire Private Capital sold 13 Labcorp shares in Q4 2024, an estimated $2.9K.
Aspire Private Capital first reported a position in Labcorp in Q2 2021 and held it in 14 quarters.
Aspire Private Capital's Labcorp position peaked at $4K in Q1 2022.
927 funds tracked by Wall St. Rank held Labcorp as of Q4 2024.

Based on Aspire Private Capital's 13F filing for Q4 2024, filed 17 Jan 2025.